Philip Morris International (NYSE:PM) is urging the U.S. Food and Drug Administration to allow the company to continue marketing its heated tobacco products in the U.S. as a “modified risk tobacco ...

A pioneer in modified risk tobacco products, Philip Morris International is the only company to have received a modified risk marketing claim for an electronic nicotine device. FDA concludes “Evidence ...

Philip Morris International Inc. PM is accelerating its shift from traditional tobacco to reduced-risk products, with strong momentum in its flagship offerings — IQOS and ZYN. In the first quarter of ...

The tobacco stock has emerged as a clear winner in the new-look nicotine and tobacco space, where traditional cigarettes and chewing tobacco are losing ground to smoke-free alternatives, such as ...

Philip Morris International is urging federal regulators to let it continue marketing its IQOS heated tobacco products in the U.S. as posing fewer health risks than traditional cigarettes. The tobacco ...

Philip Morris International’s PM smoke-free business is gaining scale, and the performance of its flagship products, IQOS and ZYN, is central to this trajectory. In the second quarter of 2025, the ...

Philip Morris International (NYSE: PM) shares hit an all-time high following its latest earnings results. The stock is now up nearly 40% in 2025, as of this writing, and over 75% in the past year. I ...

Philip Morris International shares fell after the company's second-quarter report, despite strong earnings and increased EPS guidance. The company is expecting to see cigarette sales volumes decline ...

Philip Morris International's latest valuation update nudges its fair value estimate fractionally lower to about $182.94 per share, even as the underlying investment story remains in flux. Slight ...